14.05.2013 Views

Book of Medical Disorders in Pregnancy - Tintash

Book of Medical Disorders in Pregnancy - Tintash

Book of Medical Disorders in Pregnancy - Tintash

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Prophylactic this <strong>in</strong>cludes rout<strong>in</strong>e<br />

adm<strong>in</strong>istration <strong>of</strong> iron dur<strong>in</strong>g pregnancy<br />

and lactation. Iron supplementation<br />

should start after the sixteenth week <strong>of</strong><br />

pregnancy <strong>in</strong> order to avoid <strong>in</strong>crease <strong>in</strong><br />

the early vomit<strong>in</strong>g <strong>of</strong> pregnancy. If the<br />

patient's <strong>in</strong>itial hemoglob<strong>in</strong> level is over<br />

90 per cent or 11 gram per cent then she<br />

requires only a s<strong>in</strong>gle dose <strong>of</strong> 200 mgm<br />

<strong>of</strong> ferrous sulphate. Each tablet <strong>of</strong> 200<br />

mgm <strong>of</strong> ferrous sulphate conta<strong>in</strong>s 60 mg<br />

<strong>of</strong> elemental iron. If the hemoglob<strong>in</strong><br />

level is less than 90 per cent she should<br />

receive 180mg. <strong>of</strong> elemental iron, which<br />

can be given daily <strong>in</strong> divided doses after<br />

meals.<br />

When ferrous sulphate or gluconate is<br />

not tolerated well by the patient, ferrous<br />

succ<strong>in</strong>ate or ferrous fumarate may be<br />

tried. A number <strong>of</strong> preparations such as<br />

fefol, feospan and autr<strong>in</strong> are available <strong>in</strong><br />

the market; some <strong>of</strong> these have been <strong>in</strong><br />

use for many decades without any side<br />

effects and therefore can be safely<br />

prescribed. Am<strong>in</strong>o-acids are an essential<br />

part <strong>of</strong> the hemoglob<strong>in</strong> molecule, there<br />

fore all pregnant women should be<br />

encouraged to dr<strong>in</strong>k milk and eat meat.<br />

Therapeutic:<br />

Iron <strong>in</strong> therapeutic doses can be<br />

adm<strong>in</strong>istered by oral, <strong>in</strong>tramuscular or<br />

<strong>in</strong>travenous route. Oral route is preferred<br />

<strong>in</strong> treatment <strong>of</strong> outdoor cases, while<br />

<strong>in</strong>tramuscular <strong>in</strong>jections are<br />

recommended <strong>in</strong> patients where rapid<br />

<strong>in</strong>crease <strong>in</strong> hemoglob<strong>in</strong> is needed.<br />

Some patients are unable to<br />

tolerate iron by mouth, they also need<br />

<strong>in</strong>tramuscular therapy. Some <strong>of</strong> the<br />

commonly used iron preparations for<br />

<strong>in</strong>tramuscular adm<strong>in</strong>istration <strong>in</strong>clude the<br />

follow<strong>in</strong>g.<br />

Iron sorbitol citric acid complex<br />

(Ject<strong>of</strong>er):<br />

This preparation conta<strong>in</strong>s 50 mg <strong>of</strong><br />

elemental iron <strong>in</strong> one milliliter solution.<br />

Each <strong>in</strong>jection <strong>of</strong> 2 ml. <strong>of</strong> Ject<strong>of</strong>er may<br />

be expected to raise the hemoglob<strong>in</strong> by<br />

about 0.3 gram per hundred milliliters <strong>of</strong><br />

blood.<br />

Imferon: Iron can also be given by<br />

<strong>in</strong>travenous route. Imferon is an iron<br />

dextran complex which is available <strong>in</strong> 5<br />

ml ampoules and conta<strong>in</strong>s 100 mg <strong>of</strong><br />

iron. In pregnant patients each 100 mg <strong>of</strong><br />

iron can raise the hemoglob<strong>in</strong> by about<br />

0.3 per cent. Total dose <strong>of</strong> iron required<br />

to meet deficiency <strong>of</strong> hemoglob<strong>in</strong> can be<br />

mathematically calculated by us<strong>in</strong>g the<br />

formula shown <strong>in</strong> table (31). This compound<br />

must not be allowed to leak<br />

outside the ve<strong>in</strong> as it is extremely irritant<br />

and can cause thrombophlebitis.<br />

The total dose <strong>of</strong> iron, as iron dextran, is<br />

mixed with 1000 ml <strong>of</strong> normal sal<strong>in</strong>e<br />

solution, 8,000 units <strong>of</strong> hepar<strong>in</strong> are<br />

added <strong>in</strong> this to discourage venous<br />

thrombosis. The drip should be run at a<br />

rate <strong>of</strong> 10 drops per m<strong>in</strong>ute for fifteen<br />

m<strong>in</strong>utes and then, at 45 drops a m<strong>in</strong>ute<br />

until the <strong>in</strong>fusion is completed, and this<br />

should take about five hours. The drip<br />

should be stopped on the slightest<br />

evidence <strong>of</strong> adverse reaction and 50<br />

mgm <strong>of</strong> Phenergan along with 100 mgm<br />

<strong>of</strong> hydrocortisone should be given to<br />

avert exacerbation <strong>of</strong> reactions.<br />

When iron is adm<strong>in</strong>istered<br />

<strong>in</strong>travenously, a shower <strong>of</strong> renal casts<br />

and leucocytes <strong>of</strong>ten appears <strong>in</strong> the<br />

maternal ur<strong>in</strong>e.<br />

Intravenous total dose iron therapy<br />

should be avoided <strong>in</strong> patients who have a<br />

9

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!